Pembrolizumab Inj Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 25 mg/mL
Reference Brands: Keytruda (USA/EU)
Category:
Oncology Cancer Care
Pembrolizumab is a humanized monoclonal antibody and an immune checkpoint inhibitor that targets the PD-1 (programmed death receptor-1) pathway. By blocking the interaction between PD-1 and its ligands (PD-L1 and PD-L2), Pembrolizumab enhances T-cell mediated immune responses against cancer cells.
Pembrolizumab Inj is available in Injection
and strengths such as 25 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pembrolizumab Inj is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pembrolizumab Inj can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing